Veru AdComm Highlights Differing EUA Philosophies Based On Lingering COVID-19 Deaths

 
• By Sarah Karlin-Smith
  
diverging paths with arrows
FDA advisors split on whether further study of VERU-111 should come before of after an EUA • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers